Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

Biomoda Honors Veterans with Pledge to Lower Rate of Lung Cancer

Posted : Mon, 09 Nov 2009 18:24:43 GMT
Author : Biomoda, Inc.
Category : Press Release
News Alerts by Email ( click here )
News | Home
ALBUQUERQUE, N.M. - (Business Wire) Biomoda, Inc. (OTCBB: BMOD) President John Cousins called upon governors in all 50 states to proclaim November “Lung Cancer Awareness Month” on behalf of veterans and their families and pledged to continue the company’s focus on veterans in the research, development and commercialization of diagnostic technology for detection of early-stage lung cancer.

“America can truly honor its 25 million veterans by making a commitment to fight lung cancer. Veterans have a 25 percent higher risk than the general population of developing lung cancer and dying from the disease,” Cousins said. “The men and women who served our country deserve nationwide recognition that lung cancer is a significant threat to their health, and they deserve our commitment to lower their risk with early detection and awareness.”

Based on a molecular marker technology originally developed at Los Alamos National Laboratory, Biomoda’s CyPath® assay is expected to improve the survivability of lung cancer through early detection and treatment. “As we prepare to expand our clinical trial to multiple sites across the country, we will continue to focus research on lowering the cancer burden carried by veterans, and we urge others to do the same,” Cousins said.

Cousins called upon the nation’s governors to issue proclamations declaring November “Lung Cancer Awareness Month” on Veterans Day. He applauded The Lung Cancer Alliance and its nationwide campaign to obtain proclamations from all 50 states. “The Lung Cancer Alliance continues its service to our veterans by providing the means for every governor to join in the fight and issue a proclamation that highlights the dismal statistics our veterans face and gives hope that those statistics soon will change for the better.”

Biomoda’s first product, an in-vitro test for the detection of early-stage lung cancer, is currently in Phase II clinical trials. Study volunteers provide deep-lung sputum samples to be screened for cancer cells with the CyPath® assay in the Biomoda lab. Results are compared to CT scans and Pap stains read by independent radiologists and cytopathologists, respectively, to confirm accuracy.

Biomoda (www.biomoda.com) is a cancer diagnostics company focused on the development of accurate, inexpensive and noninvasive tests for the early detection of cancer in large populations. In addition to its first product for lung cancer, diagnostic assays for cervical, breast, colorectal, bladder, and oral cancers are targeted for development.

Biomoda, Inc.
John Cousins, 505-821-0875


Copyright © 2008 Business Wire. All rights reserved.
Share/Save/Bookmark

Article : Biomoda Honors Veterans with Pledge to Lower Rate of Lung Cancer
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

Power Tagging Announces National Science Foundation Grant
Company Selected Amongst Thousands to Continue to Evolve Data Structures to Support the Emerging NIST Smart Grid Standards./I/P P(PRWEB) November 22, 2009 -- Power Tagging, a leading provider of next generation smart grid communications technologies, today announced that the company has...

2011 Cadillac CTS Coupe: New Sports Coupe Is Cadillac's Most Dramatic Design
LOS ANGELES, Nov. 23 /PRNewswire/ -- Cadillac today unveiled the 2011 CTS Coupe, the latest and most dramatic of the brand's series of new designs to reach production. Slated to arrive in Cadillac showrooms in the spring of 2010, the CTS Coupe is a new luxury sports coupe designed t...

U.S. Census Bureau Daily Feature for Nov. 23
WASHINGTON, Nov. 23 /PRNewswire-USNewswire/ -- Following is the daily "Profile America" feature from the U.S. Census Bureau: (Logo: http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO)

Majorities Reject Banning Defamation of Religion: 20 Nation Poll
COLLEGE PARK, Md., Nov. 23 /PRNewswire-USNewswire/ -- As the UN General Assembly prepares to debate a proposal calling for nations to take action against the defamation of religion, majorities in 13 of 20 nations polled around the world support the right to criticize a religion.

Amid the Flu Epidemic, Don't Forget RSV in Young Children
RSV found to cause far more emergency department visits and hospitalizations than seasonal flu BOSTON, Nov. 23 /PRNewswire-USNewswire/ -- Influenza, particularly H1N1, has understandably captured the attention of public health officials, the media and the public...

Peter Wilkinson Appointed IPREX President Asia Pacific
ATLANTA - Peter Wilkinson, CEO of Wilkinson PR, a full service corporate affairs and public relations agency with offices in Sydney, Melbourne and Perth, has been appointed President Asia Pacific of IPREX, the global corporation of independent public relations and communication firms.

Report Finds Girls' Schools in Afghanistan Face Highest Risk of Violence; Suggests Steps for Preventing Attacks
- New study supports community-based approach to education in Afghanistan - ATLANTA, Nov. 23 /PRNewswire-USNewswire/ -- Today CARE, the World Bank and the Afghanistan government released "Knowledge on Fire: Attacks on Education in Afghanistan," a groun...

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.